The largest database of trusted experimental protocols
> Disorders > Pathologic Function > Sudden Death

Sudden Death

Sudden Death refers to the unexpected and rapid cessation of cardiac activity, leading to the abrupt loss of conciousness and ceassation of breathing.
This can be caused by a variety of cardiovascular conditions, such as arrhythmias, coronary artery disease, or cardiomyopathies.
Prompt recognition and management of Sudden Death is crucial, as it often requires immediate cardiopulmonary resuscitation and defribillation to restore normal heart function.
Understanding the risk factors and underlying causes of Sudden Death is an important area of medical research aimed at improving prevention and treatment strategies.

Most cited protocols related to «Sudden Death»

We invited all young adults working or studying at UK higher education institutions (HEIs) to participate in a closed, online study about sudden bereavement: the UCL Bereavement Study. We anticipated that using the email systems of large institutions would be the best means of accessing hard-to-reach groups, particularly those not normally accessing health services, and avoiding the biases associated with recruiting a help-seeking sample.18 (link) Sampling from a diverse range of colleges, universities, art and drama schools, and agricultural colleges offered unique access to a large defined sample of young adults.
All 164 HEIs in the UK in 2010 were invited to participate, following up non-responding HEIs to encourage broad socioeconomic and geographic representation. Over 20% of HEIs (37/164) agreed to take part, with a higher response (40%) from those classified as the more prestigious Russell Group of universities. This provided a sampling frame of 659 572 staff and students. All participants were invited to take part in a survey of ‘the impact of sudden bereavement on young adults’, with the aim of masking them to the specific study hypotheses. There was no accurate way of measuring response, as the denominator of bereaved people was not ascertainable using routine data or survey methods. The majority of participating HEIs agreed to send an individual email invitation with embedded survey link to each staff and student member. For reasons of sensitivity (recent staff/student deaths), 10 HEIs modified this strategy, for example, by emailing students only, using their weekly news digest email, or advertising via staff and student intranet.
Inclusion criteria were as follows: people aged 18–40 who, since the age of 10, had experienced sudden bereavement of a close friend or relative. The 18–40 age range was defined to reflect an under-researched group of great policy interest.16 (link) Early childhood bereavements were excluded to minimise recall bias and restrict our focus to adult cognitive processing of life events, using the age threshold for criminal responsibility in England and Wales. A close contact was defined as ‘a relative or friend who mattered to you, and from whom you were able to obtain support, either emotional or practical’. Sudden bereavement was operationalised as ‘a death that could not have been predicted at that time and which occurred suddenly or within a matter of days’. Exposure status was classified by responses to the question: ‘Since you were aged 10 have you experienced a sudden bereavement of someone close to you due to any of the following: (1) sudden natural death (eg, cardiac arrest, epileptic seizure, stroke); (2) sudden unnatural death (eg, road crash, murder or manslaughter, work accident); (3) suicide?’ Mode of death was defined subjectively by the respondent, and not by coroner's verdict or death certificate, as perception of bereavement type was the exposure of interest.
In the case of more than one exposure, we adopted a hierarchical approach favouring those bereaved by suicide, for whom we anticipated the lowest base rate. This group were classified as suicide bereaved regardless of other exposures. Those bereaved by more than one non-suicide sudden death were asked to relate their responses to whichever person they had felt closest to, with exposure status classified accordingly.
We estimated that a minimum of 466 participants would be required in any one group (two-tailed analysis; 90% power) to detect a doubling of the UK community prevalence of lifetime suicide attempt (6.5%) in young adult samples.19 We chose a relatively large effect size to reflect our comparison to a non-bereaved baseline, lacking prevalence figures for bereaved UK samples.
Full text: Click here
Publication 2016
Accidents Adult Bereavement Cardiac Arrest Cerebrovascular Accident Criminals Emotions Epilepsy Feelings Friend Grief Hypersensitivity Interest Groups Mental Recall Reading Frames Student Sudden Death Suicide Attempt Young Adult
Seizures and seizure-induced sudden death were evoked either by acoustic stimulation or by the proconvulsant PTZ, as described previously.22 (link),30 (link) To induce AGSz in DBA/1 mice, each mouse was placed in a cylindrical acrylic glass chamber in a sound-isolated room. AGSz were induced by acoustic stimulation using an electric bell (96 dB SPL) (UC4-150, Zhejiang People’s Electronics, China). The acoustic stimulus was given for a maximum duration of 60 s or until the mouse exhibited tonic seizures, which culminated in tonic hindlimb extension and S-IRA. Mice with S-IRA were resuscitated within 5 s after the final respiratory gasp using a rodent respirator (Harvard Apparatus 680, Holliston, MA, U.S.A.).22 (link) The susceptibility to S-IRA in primed DBA/1 mice was always reconfirmed 24 h before drug or vehicle administration. In the acute treatment protocol, 5-HTP (100–150 mg/kg) or vehicle was administered intraperitoneally 1 h before induction of S-IRA. In the repeated treatment protocol, 5-HTP (50–100 mg/kg, i.p.) or vehicle was administered once a day for 2 days, and induction of S-IRA was performed 1 h after the second administration. The volume injected was 0.1–0.3 ml for each mouse. S-IRA and AGSz behaviors were videotaped for offline analysis. Recovery of S-IRA susceptibility in DBA/1 mice was tested 24 h after drug administration or at 24-h intervals thereafter until the S-IRA susceptibility returned.
Generalized clonic and/or tonic–clonic seizures were also induced in separate groups of DBA/1 and C57BL/6J mice by systemic administration of PTZ (75 mg/kg, i.p.). 5-HTP (100–200 mg/kg) or vehicle was administered once a day for 2 days, and i.p. PTZ was administered 1 h after the second treatment.
5-HTP (Cat # 107751) and PTZ (Cat # P6500) were purchased from Sigma-Aldrich (St. Louis, MO, U.S.A.) and dissolved in saline for systemic administration.
Publication 2016
5-Hydroxytryptophan Acoustics Acoustic Stimulation Clonic Seizures, Tonic Electricity Hindlimb Mechanical Ventilator Mice, Inbred C57BL Mice, Inbred DBA Mus Pharmaceutical Preparations Respiratory Rate Rodent Saline Solution Seizures Sound Sudden Death Susceptibility, Disease Tonic Seizures Treatment Protocols
Detailed methods have been published earlier (6 (link), 11 (link)). Briefly, the ongoing Oregon Sudden Unexpected Death Study (Ore-SUDS) prospectively identified all cases of SCD that occurred among residents of the Portland, OR metropolitan area (pop. approx. 1,000,000) during Feb 2002-Jan 2005 from the emergency medical response system, the Medical Examiner’s office, and local hospitals. During Feb 2005-Jan 2006, identification was limited to the majority subset identified by first responders or investigated by the medical examiner. SCD was defined as a sudden unexpected pulseless condition of likely cardiac etiology. If un-witnessed, SCDs were those in which patients were found dead within 24 hours of having last been seen alive and in normal state of health. Subjects with likely SCD were assigned a diagnosis of SCD after a review of available medical records and the circumstances of arrest; survivors of SCD were included. Subjects with chronic terminal illnesses (e.g. cancer), known non-cardiac causes of sudden death (e.g. pulmonary embolism, CVA), traumatic deaths and overdoses were excluded. Cases were also required to have documented significant CAD or if aged ≥50 years were assumed to have CAD (based on 95% likelihood of CAD in SCD cases aged≥50 years) (12 (link), 13 ). CAD was defined as ≥50% stenosis of a major coronary artery or history of myocardial infarction, coronary artery bypass grafting or percutaneous coronary intervention.
During the same time period a control group of subjects from the same geographic region were identified who had CAD, but no history of SCD. They had either been transported by the Emergency Medical Response system for complaints suggestive of ongoing coronary ischemia, recruited from clinics of participating health systems, or received a coronary angiogram revealing significant CAD. After consent was obtained, medical records for each potential control subject were reviewed; those with documented CAD (as defined above) were enrolled.
Publication 2009
Anemia, Sickle Cell Coronary Angiography Coronary Arteriosclerosis Coronary Stenosis Diagnosis Disease, Chronic Drug Overdose Emergencies Emergency Responders Heart Heart Diseases Malignant Neoplasms Myocardial Infarction Patients Percutaneous Coronary Intervention Pulmonary Embolism Sudden Death Survivors Takayasu Arteritis Vision
The LEC (Blake et al., 1990 ) is a 17-item, self-report measure designed to screen for potentially traumatic events (PTEs) in a respondent’s lifetime. The LEC was designed as a companion measure for the CAPS-IV. The LEC assesses exposure to 16 events known to potentially result in PTSD and includes one additional item which allows for a respondent to indicate another extraordinarily stressful event not captured by the first 16 items. For each event, respondents are asked to choose one or more response, including happened to me, witnessed it, learned about it, not sure, and doesn’t apply. The LEC has demonstrated convergent validity with other measures designed to assess exposure to PTEs (Gray, Litz, Hsu, & Lombardo, 2004 (link)). In Sample 1, the LEC was used to assess exposure to PTEs and identify the index event; the CAPS was then used to assess whether the index event met Criterion A.
This was a highly traumatized sample: On average, participants endorsed directly experiencing 6.95 PTE categories (SD = 3.34). Using the LEC categories, the most frequently endorsed category was physical assault (n = 127, 76.0%); followed by transportation accident (n = 120, 71.9%); assault with a weapon (n = 108, 64.7%); life threatening illness or injury (n = 96, 57.5%); sudden, unexpected death of someone close (n = 96, 57.5%); natural disaster (n = 86, 51.5%); combat/warzone exposure (n = 83, 49.7%); fire or explosion (n = 77, 46.1%); serious accident (n = 70, 41.9%); exposure to toxic substance (n = 60, 35.9%); unwanted sexual experience other than sexual assault (n = 58, 34.7%); sexual assault (n = 53, 31.7%); causing serious injury, harm, or death to someone else (n = 44, 26.4%); other severe human suffering (n = 41, 24.6%); witnessing sudden, violent death (n = 33, 19.8%); and captivity (n = 18, 10.8%).
Publication 2017
Accidents Explosion Homo sapiens Injuries Natural Disasters Pets Physical Examination Poisons Post-Traumatic Stress Disorder Sexual Assault Sudden Death
Mice were ear tagged and tail-biopsied on postnatal day 14 (P14). At P21,
N2 backcross mice were weaned into holding cages containing 4-5 mice of the same
sex and age. Mice of both sexes were used and wildtype littermates were included
in all holding cages. Survival was monitored to 12 weeks of age. During that
time, all mice were monitored daily for general health and any mouse that was
visibly unhealthy (e.g. stunted, underweight, dehydrated, poorly groomed,
immobile) was euthanized and excluded from the study. We used survival as the
primary phenotype measure for our mapping study. Deaths in the
Scn1a+/− mice were sudden and
unpredictable, occurring in otherwise healthy appearing animals. Occasionally,
generalized tonic clonic seizures (GTCS) of short duration (<2 minutes)
were witnessed. GTCS were followed by a short period of post-ictal immobility,
but recovery was attained within 10 minutes. Following a witnessed GTCS, death
was often recorded in the subsequent 24 hours. It has previously been
demonstrated that sudden death is strongly correlated with seizure history in
the Scn1a+/− mouse model (Kalume et al 2013 (link)).
Publication 2013
Animals Cerebrovascular Accident Clonic Seizures, Tonic Mice, Laboratory Phenotype Seizures Sudden Death Tail

Most recents protocols related to «Sudden Death»

This meta-analysis was registered in PROSPERO (CRD42021260724). We followed the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) guidelines for this meta-analysis. Two independent investigators (Yang Wu and Wen-Tao Bi) performed the literature search using Medline, EMBASE databases and ClinicalTrials.gov. The computer-based searches included the keywords “macrolides,” “azithromycin,” “erythromycin,” “clarithromycin,” “roxithromycin,” “cardiac,” “heart,” “cardiovascular,” “death,” “stroke,” “myocardial infarction,” “acute coronary syndrome,” “ventricular tachycardia,” “arrhythmia,” “sudden cardiac death,” “cardiac arrest,” “torsades de pointes,” “sudden death,” and “mortality.”
Full text: Click here
Publication 2023
Acute Coronary Syndrome Azithromycin Cardiac Arrest Cardiac Arrhythmia Cardiovascular System Cerebrovascular Accident Clarithromycin Erythromycin Heart Macrolides Myocardial Infarction Roxithromycin Sudden Cardiac Death Sudden Death Tachycardia, Ventricular Torsades de Pointes
We searched the Web of Science Core Collection databases, including the Science Citation Index and Social Science Citation Index, on October 1, 2022 to identify studies regarding SUDEP published from 2002 to 2022. The search strategy was (TS=sudden unexpected death in epilepsy OR TS=SUDEP) OR (TS=sudden unexpected death AND TS=epilepsy).
Full text: Click here
Publication 2023
Epilepsy Sudden Death
Using the IHME's “Global Burden of Disease” search engine, under causes of death, we used the search criteria of measures (deaths, incidence, and prevalence), locations (the six countries), age groups from early neonatal to 14 years, and the year 2019.9 Data were input into Apple Numbers spreadsheet software. Finally, we excluded sudden deaths and nondisease causes of death such as suicide and accidents.
Pediatric deaths attributable to known diseases or medical conditions were identified and grouped into five categories: neonatal conditions, infectious diseases, neoplastic diseases, congenital (including genetic) disorders, and other diseases. We then evaluated the different diseases and allocated them to the four groups described in the TFSL guide. Finally, an evidence-based approach was used to estimate children living with those fatal diseases (see Table 1). Data were analyzed and tabulated in Tables 2 and 3.
Full text: Click here
Publication 2023
Accidents Age Groups Child Communicable Diseases Hereditary Diseases Infant, Newborn Neoplasms Sudden Death
The primary composite endpoints of our study were any recurrent MIs, revascularization, sudden death/ventricular arrhythmia, HF hospitalization, stroke or CV mortalities, and all-cause mortality rate during the 1- and 3-yearfollow-up periods. The secondary composite endpoints included all in-hospital events, such as in-hospital mortality, acute kidney injury, and postprocedural hemodialysis (HD).
Full text: Click here
Publication 2023
Cardiac Arrhythmia Cerebrovascular Accident Heart Ventricle Hemodialysis Hospitalization Kidney Failure, Acute MLL protein, human Sudden Death

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2023
Amino-terminal pro-brain natriuretic peptide Anti-Arrhythmia Agents Antibiotics Becker Muscular Dystrophy Biopsy Cardiac Arrhythmia Chest Pain Congenital Heart Defects Creatine Kinase Creatinine Diagnosis Dyspnea Echocardiography Electrocardiogram Electrocardiography, 12-Lead Electromyography Ethics Committees, Research Fluoroquinolones Gender Heart Heart Diseases Macrolides Mitochondrial Diseases Muscle Weakness Muscular Dystrophies, Limb-Girdle Myotonic Dystrophy Neuromuscular Diseases Patients Pharmaceutical Preparations Serum Skeletal Muscles Sudden Death Syncope Tricyclic Antidepressive Agents Troponin T

Top products related to «Sudden Death»

Sourced in United States, Germany, China, Japan, United Kingdom, Canada, France, Italy, Spain, Australia, Switzerland, Belgium, Denmark, Netherlands, India, Ireland, Lithuania, Singapore, Sweden, Norway, Austria, Brazil, Argentina, Hungary, Sao Tome and Principe, New Zealand, Hong Kong, Cameroon, Philippines
TRIzol is a monophasic solution of phenol and guanidine isothiocyanate that is used for the isolation of total RNA from various biological samples. It is a reagent designed to facilitate the disruption of cells and the subsequent isolation of RNA.
Sourced in Japan, China, United States, France, Germany, Switzerland, Canada, Sweden, Puerto Rico, Singapore
The PrimeScript RT reagent kit is a reverse transcription kit designed for the synthesis of first-strand cDNA from RNA templates. The kit includes RNase-free reagents and enzymes necessary for the reverse transcription process.
Sourced in United States
The Empower DataWeb is a software tool designed for data management and analysis. It provides a platform for users to store, organize, and process data from various sources.
Sourced in Italy
The ECT unit is a laboratory equipment designed for Electroconvulsive Therapy (ECT) research. It generates and delivers controlled electrical stimuli to induce seizures in experimental subjects. The device's core function is to provide a reliable and consistent method for administering ECT in a controlled laboratory setting.
Sourced in United States, Germany, Japan, China, Lithuania, Canada, Switzerland, United Kingdom, Italy, Australia, Spain, France, Singapore, Russian Federation, Poland
PowerUp SYBR Green Master Mix is a ready-to-use solution for real-time PCR amplification and detection. It contains SYBR Green I dye, Dual-Lock DNA polymerase, and necessary reagents for efficient and sensitive quantification of DNA targets.
Sourced in United States, Australia, United Kingdom, New Zealand, Germany, Colombia, Canada, China
LabChart is a data acquisition and analysis software developed by ADInstruments. It is designed to collect, visualize, and analyze various types of physiological and scientific data. LabChart provides a user-friendly interface for real-time data recording, processing, and reporting.
Sourced in Netherlands
The MiRNeasy FFPE minikit is a laboratory equipment product by Qiagen designed for the purification of total RNA, including small RNAs, from formalin-fixed, paraffin-embedded (FFPE) tissue samples.
Sourced in United Kingdom
Ab142155 is a lab equipment product from Abcam. It serves as a core function, but a detailed description while maintaining an unbiased and factual approach is not available.
Sourced in United States, China, Japan, Germany, United Kingdom, Canada, France, Italy, Australia, Spain, Switzerland, Netherlands, Belgium, Lithuania, Denmark, Singapore, New Zealand, India, Brazil, Argentina, Sweden, Norway, Austria, Poland, Finland, Israel, Hong Kong, Cameroon, Sao Tome and Principe, Macao, Taiwan, Province of China, Thailand
TRIzol reagent is a monophasic solution of phenol, guanidine isothiocyanate, and other proprietary components designed for the isolation of total RNA, DNA, and proteins from a variety of biological samples. The reagent maintains the integrity of the RNA while disrupting cells and dissolving cell components.
Sourced in United States, Germany, China, Macao, Sao Tome and Principe, United Kingdom, Japan, Canada, Switzerland, Australia, France
Ang II is a peptide hormone that is involved in the regulation of blood pressure and fluid balance in the body. It is a key component of the renin-angiotensin-aldosterone system (RAAS), which plays a central role in the homeostatic control of blood pressure, fluid, and electrolyte balance. Ang II acts on specific receptors to exert its physiological effects.

More about "Sudden Death"

Sudden cardiac death (SCD), also known as sudden unexpected cardiac death (SUCD), is the unexpected and abrupt cessation of cardiac activity, leading to the sudden loss of consciousness and breathing.
This devastating condition can be caused by a variety of cardiovascular issues, including arrhythmias, coronary artery disease, and cardiomyopathies.
Prompt recognition and management of SCD is crucial, as it often requires immediate cardiopulmonary resuscitation (CPR) and defibrillation to restore normal heart function.
Understanding the risk factors and underlying causes of SCD is an important area of medical research aimed at improving prevention and treatment strategies.
SCD can be triggered by a range of factors, such as genetic predispositions, lifestyle choices, and underlying medical conditions.
Conditions like long QT syndrome, hypertrophic cardiomyopathy, and Brugada syndrome are known to increase the risk of SCD.
Additionally, factors like TRIzol reagent, PrimeScript RT reagent kit, Empower DataWeb, ECT unit, PowerUp SYBR Green Master Mix, LabChart, MiRNeasy FFPE minikit, Ab142155, and Ang II can all play a role in the complex pathophysiology of this condition.
Early recognition of SCD risk factors and prompt intervention are key to saving lives.
Healthcare professionals must be vigilant in monitoring patients for signs of cardiac arrhythmias, coronary artery disease, and other underlying conditions that may predispose them to SCD.
Advances in medical technology, such as improved ECG monitoring and implantable cardioverter-defibrillators, have greatly improved the chances of survival for those at risk of SCD.
However, more research is still needed to fully understand the mechanisms behind this devastating condition and develop even more effective prevention and treatment strategies.